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Available online 7 October 2016AbstractIn the 1930's Alan Barach introduced helium in combination with oxygen, heliox, to the medical world. He found that helium's physical
properties help reduce the work of breathing, reduce airway resistance, and subsequently improve alveolar ventilation in obstructed airways. In
the presence of airway narrowing, heliox has the benefits of increasing the tendency to laminar flow (which has lower resistance) and reducing
resistance when turbulent flow occurs. Heliox, a heliumeoxygen mixture, has since been used sporadically and only scattered reports are found
on its use for treatment in patients with upper airway obstruction. The aim of the present review was to search and review the available evidence
for its safe and effective clinical use. A total of 20 publications about the use of helium-containing gas mixture for the treatment of upper airway
obstruction in adults were found in the search of public domain literature. Most case reports describe short-term beneficial effects, temporarily
improving breathing and oxygenation. Authors of the case reports suggest heliumeoxygen mixture as an optional bridge, while a more definite
treatment takes action. There are, however, no prospective randomized controlled studies and thus there is lack of high-quality proof supporting
its safe and efficacious use. In conclusion, the physiochemical properties promoting laminar flow in restricted airways and the sparse but still
seemingly positive clinical experience favor the use of heliumeoxygen mixture as a symptomatic rescue therapy. The risk for side effects, apart
from the reduced oxygen concentration in the inspired gas, seems minor. There is, however, still a lack of evidence to support the general use of
oxygenehelium mixture for upper airway compromise due to the sparse information available. Further studies, although not easily designed, are
warranted.
Copyright © 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Helium was discovered in the sun in 1868 and is named
after Helios, the God of the sun in Greek mythology. Helium,
being compound number 2 in the periodic table, has the lowest
density of any gas except for hydrogen.1 Helium is a colorless,
odorless and tasteless gas. It is biologically and metabolically
inert, poorly soluble, and noncombustible. It is considered safe
and nontoxic to humans and is eliminated within a few
breaths.1e3 An equivalent volume of air weighs seven times* Corresponding author. Department of Anaesthesia, Danderyds Hospital,
182 88 Stockholm, Sweden.
E-mail address: jan.jakobsson@ki.se (J.G. Jakobsson).
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2211-5587/Copyright © 2016, Taiwan Society of Emergency Medicine. Published
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).more than helium (Table 1). Helium also has a different ther-
mal conductivity and if inhaled for a long period of time may
cause a change in core temperature, resulting in hypothermia.
In the early 1930's Alan Barach made pioneer studies with
helium in combination with oxygen: “heliox”. He hypothe-
sized that when oxygen and helium are mixed in a ratio of
20% to 80%, respectively, the mixture possesses one-third of
the density compared to air, with the consequence that a pa-
tient could either breathe the mixture with one-third of the
working load, or ventilate the lung with three times the volume
for the same respiratory effort as used for air.4 Barach was able
to show in experimental setting that helium's physiochemical
properties improve the flow of gas in the airway tract by
reducing airway resistance. In the presence of airwayby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-
Table 1
Physical properties of pure gases at RTP2.
Density
(kg/m3)
Viscosity
(mP)
Thermal conductivity
(W/m K)
Air 1.184 184.33 0.025
CO2 1.811 148.71 0.017
Helium 0.166 197.61 0.14
Nitrogen 1.167 177.82 0.126
Oxygen 1.33 205.35 0.026
RTP, Room Temperature and Pressure.
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dency to laminar flow (which has lower resistance) and re-
duces resistance when turbulent flow occurs. This in turn
reduces the work of breathing and improves alveolar ventila-
tion and subsequently the concentration of oxygen.4 Helium
gas mixture not only facilitates alveolar ventilation but also
decreases the work of breathing in respiratory-distressed pa-
tients and thus reduces the amount of CO2 produced.
1
Further work on the physiochemical properties was done
by Houck et al,5 investigating the effect of helium concen-
tration in inspired gas on resistance to breathing during
experimental upper airway obstruction in healthy volunteers.
Obstruction was modelled by the use of a series of four
polyvinyl endotracheal tubes, narrowed progressively in their
midportions with C clamps. Four heliumeoxygen gas mix-
tures were studied; 0:100, 40:60, 60:40, and 80:20, respec-
tively, with a flow rate of 10 L/min. The main findings were
that the effect of helium on reducing resistance and pressure
in an obstructed airway was linear and inversely proportional
to helium concentration, and further that the reductions in
resistance and pressure were larger for the tighter obstruc-
tions. Fleming et al6 confirmed the effects of an 80:20 heli-
umeoxygen gas mixture in an experimental setting. They
studied 30 healthy volunteers breathing room air or an 80:20
heliumeoxygen mixture through a normal airway and an
airway that included a resistor. They found an increase in
1 second forced expiratory volume using a heliumeoxygen
mixture in a normal airway and that all pulmonary function
test scores statistically improved when volunteers inspired
helium and oxygen through the restricted airway, demon-
strating that helium and oxygen can increase airflow in the
presence of an increased airway resistance. Thus, the higher
the concentration and the more narrow the airway, the higher
the impact of the helium gas. Effects are seen rapidly, and are
not dependent on uptake and pharmacological action, directly
associated to the physiochemical properties of the gas. Like-
wise, helium is completely eliminated in a few breaths.2
Helium per se has no curative action but a heliumeoxygen
gas mixture may “buy time” while awaiting treatment that is
aimed at alleviating the obstruction. Since the pioneer work of
Barach, heliumeoxygen mixtures have been tested for a va-
riety of different causes of respiratory distress. It has been
tested in upper airway obstruction due to foreign body, tumor,
edema, vocal cord pathology, and croup in children. It has
also been described as having a place in the treatment of
severe asthma and chronic obstructive pulmonary disease,reducing the work of breathing and thus facilitating the
alveolar ventilation and gas exchange. Furthermore, it has
been tested during weaning from mechanical ventilation to
facilitate breathing in the early extubation phase and partic-
ularly in patients showing signs of postextubation croup.
Heliumeoxygen mixture has been tested in combination with
jet-ventilation and has been studied as the carrier gas for
nebulization of inhalable drugsdto “carry” the drug further
down the airway tract.1
The aim of the present review is to provide an update of
available literature supporting heliumeoxygen gas mixtures as
therapy in adult patients with signs and symptoms of upper
airway obstruction/distress. Public domain literature from
1935 until the present day, describing the use of helium in
patients with primarily upper airway obstructions, is reviewed.
2. Materials and methods
We searched for relevant publications in the electronic
database PubMed using the terms “helium” OR “heliox”,
AND “upper airway obstruction”. The inclusion criteria were:
(1) English language; (2) humans; (3) adults aged >18 years.
A secondary search was performed by retrieving relevant pa-
pers and articles from the references of the primary search
results (Figure 1).
Due to its high volatility, helium must be administered in
very high flow rates (10e15 L/min) in order to guarantee the
concentration delivered.4 Also, the mode of administration is
important because a higher concentration of helium in the gas
mix achieves a laminar gas flow. Therefore flow rate, gas
concentration, and mode of administration have been looked
into in more detail in the described cases.
3. Results
From the PubMed search and secondary search we found
14 case reports, two case series, including a total of 15 pa-
tients, and four studies starting with Barach and Eckman's7
1936 paper “The effects of inhalation of helium mixed with
oxygen on the mechanics of respiration”.3.1. Case reports and seriesIn total there are 29 patients described. The published case
reports cover a wide and scattered range of indications, tech-
niques, and conditions related to upper airway obstructions.
Information on gas flow, gas composition, and mode of
administration is presented in four cases only. Available in-
formation is summarized in Table 2.
Positive effects of the administration of helium gas mixture
dominate the case reports and series (Table 3), however, the
study by Berkenbosch et al8 did not show consistent benefits,
6/16 showed a positive response. No adverse effects were re-
ported anywhere.
The case reports and the case series are from 1976 to 2012.
A total of 26 of 29 patients were treated in North America
(Tables 4 and 5).
Database search:
“helium OR heliox AND 
airway obstruction”
Filter: English/adults
(n = 95)
Database search:
“helium OR heliox AND 
upper airway obstruction”
Filter: English/adults
(n = 17)
Narrowing down too large
result set
Secondary search:
Select references from 
primary result
(n = 21)
Relevant publications
(n = 33)
Case reports
(n = 14)
Excluding other indications 
(n = 5)
Primary result
(n = 12)
Case series
(n = 2)
Studies
(n = 4)
Review papers
(n = 12)
Figure 1. Search process for relevant papers and articles.
Table 2
Information in case reports and case series.
Gas flow Gas composition Mode of administration No. of patients
þ þ þ 4
þ þ d 3
þ d d 7
d þ þ 8
d d d 2
d þ d 5
Table 3
Outcomes by type of article (n).
Positive No effect Adverse effects
Case reports 14 0 0
Case series 14 1 0
Berkenbosch et al study8 6 10 0
Total 34 11 0
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kenbosch et al8 in 2004 presented a prospective multicenter
case series of heliox use in the critical care environment. It
extended over a 4-year period with 89 patients, of which 16
were adults, with upper airway obstruction (Table 3). From
their observations they suggest that clinically important effects
of helium may occur over a wider range of heliumconcentrations than previously believed. They conclude that
heliumeoxygen gas mixture use should continue to be tested
due to lack of adverse effects, rapidity of onset, and relatively
low cost. They also conclude that further studies are
warranted.8
4. Discussion
In theory, the physiochemical properties of heliumeoxygen
gas mixture support its use by making the gas flow through the
respiratory tract in a laminar flow and less turbulent than air or
Table 4
Case reports summarized.
Author Year Location Case of UAO Mix (He:O2) Admin method Flow rate
(L/min)
Patients (n)
Lu et al9 1976 US Narrowed main-stem bronchus 70:30 Intubated 5 1
Rudow et al10 1986 US Thyroid carcinoma 78:22 Tight fitting mask ? 1
Curtis et al11 1986 US Inoperable AO 80:20 Non-rebreeding mask 12 1
Mizrahi et al12 1986 Israel Hilar nodes ? ? ? 1
Mallet et al13 1989 US In labor, delivery 80:20 ? ? 1
Boorstein and Humphries14 1989 US Tracheal angioedema 80:20 Non-rebreeding mask ? 1
Tan et al15 1990 US Tumor distal trachea 72:28 Intubated ? 1
Salomons and Livesey16 1990 UK Vocal cord 50:50 Nebulizer (adrenaline) ? 1
Milner et al17 1997 UK Gardner, thyroid 80:20 Non-rebreeding mask ? 1
Fu et al18 1999 Canada Supraglottitis 70:30 Non-rebreeding mask ? 1
Khanlou and Eiger19 2001 US Laryngeal dysfunction 80:20 ? ? 1
Tobias20 2009 US Subglottic stenosis 80:20 Operating laryngoscope, side channel 6 (child, 33 kg) 1
Christofer et al21 2002 US Vocal cord 70:30 ? ? 1
St-Onge et al22 2012 Canada Postextubation ? ? ? 1
UAO ¼ upper airway obstruction.
Table 5
Case series summarized.
Author Year Location Case of UAO Mix (He:O2) Admin method Flow rate (L/min) Patients (n)
Skrinskas et al23 1983 Canada 1 Healthy patient
4 Postextubation
3 Radiation therapy
3 Primary tumor
80:20
(2 pt)
70:30
(2 pt)
? (7 pt)
Mask (1 pt)
? (9)
? (1 pt)
10e15
(10 pt)
10
Smith and Biros24 1999 US 3 Children croup
1 Adult supraglottitis
1 Adult laryngeal polyps, edema
80:20
(5 pt)
Mask (2 pt)
? (3 pt)
? (4 pt)
15 (1 pt)
5
UAO ¼ upper airway obstruction.
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to support that the theory works in practice. The potential
benefits around helium for the handling of upper airway
obstruction is addressed is several review papers but the actual
critical information in humans is limited to the papers pre-
sented in our results.1e4,25e32
We found only sparse information and there are obvious
deficits in the evidence to support its general use. There are no
studies that are controlled, blinded, or randomized and they do
not in unison speak for or against the use of heliumeoxygen
mixture or give clear indications of when and how it should be
used in situations of upper airway obstruction. The literature
mostly consists of case reports or case series describing single
patients without proper controls or cross-over design. In the
cases described there are great variations in indications. Also,
administration methods, gas concentration, and flow rate var-
ies, or information is missing regarding these parameters as
seen in the results. Most notably, only four out of 29 had all
these parameters included. This makes the reports difficult to
compare and hard to draw any systematic conclusion from.
Some aspects of the reports stand out though. In 28 of 29 cases
a positive outcome of the administration was indicated.
However this is not in line with the prospective study of
Berkenbosch et al8 where only six of 16 patients showed clear
benefits from the helium gas mixture administered. No adverse
effects were reported in any of the reviewed cases. This is alsotrue for the study of Berkenbosch et al.8 Together with the
theoretically benign characteristics of helium, this suggests
that the risk of using heliumeoxygen mixture is small.
A vast majority (26 out of 29) of patients described were
treated in North America, suggesting a geographical bias. The
case reports and the case series are evenly scattered from 1976
to 2012. The frequency of reporting is low, but there is no
pattern to draw any conclusion from regarding the frequency
of use over time. Limited reporting might imply limited use, or
limited conclusive evidence of (positive or negative) effects.
Heliox is primarily used in acute clinical situations, where the
conditions mean that such conclusive evidence is hard to
determine. In the UK and some other countries the premix
helium/oxygen 79:21 is available and can easily be adminis-
tered by facemask,3 however due to the physiochemical
properties, the difference in density administration in venti-
lators must be carried out with caution.33 Administering he-
lium gas mixture during mechanical ventilation may interfere
with ventilator functioning and the accuracy of the pneumo-
tachometer.34 The oxygen saturation must be monitored,
recalling that the reduced work of breathing and subsequent
improved alveolar ventilation/gas exchange may not
completely eliminate hypoxemia.
There are obvious limitations in the evidence of support
and missing evidence for the proper benefit versus risk
assessment of heliumeoxygen mixture in upper airway
81A. Borglund Hemph, J.G. Jakobsson / Journal of Acute Medicine 6 (2016) 77e81obstruction. Systematic studies have been performed in pa-
tients with acute asthma and in children with bronchiolitis and
here meta-analysis shows ambiguous results.3,25 The use of
helium as the driving gas for nebulization of broncho-dilating
agents seems, however, to have clear benefits in improving
peripheral drug deposit and effect.26
5. Conclusion
Heliumeoxygen gas mixtures have been used sporadically
since 1934. The physiochemical properties of helium in pro-
moting laminar flow in restricted airways and the described
cases suggests positive effects of helium in upper airway
obstruction, especially in the more severe cases and there are
no reports of adverse effects. There is still, however, lack of
support by means of controlled studies; no controlled, ran-
domized, blinded, or major systematic cohort studies on he-
lium in upper airway obstruction, supporting its safe and
efficacious use, are available. Further studies are warranted.
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